TAPSE/RVSP ratio as an echocardiographic marker of residual risk in HFrEF patients receiving vericiguat
11 December 2025 (08:00 - 15:30)
Organised by: 

About the speaker

Korea University Anam Hospital, Seoul (Korea (Republic of))
4 More presentations in this session
Doctor E. Stavropoulou (Thessaloniki, GR)
Associate Professor B. Kim (Busan, KR)
Doctor M. Friedrich (Montreal, CA)
Access the full session
The Event
EACVI 2025
11 December - 13 December 2025
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation

